{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T01:32:43Z","timestamp":1791163963541,"version":"4.1.0"},"reference-count":86,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.addr.2010.09.013","type":"journal-article","created":{"date-parts":[[2010,10,4]],"date-time":"2010-10-04T05:24:00Z","timestamp":1286169840000},"page":"1167-1174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":150,"title":["Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors"],"prefix":"10.1016","volume":"62","author":[{"given":"Todd","family":"Meyerrose","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Pontow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanos","family":"Kalomoiris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunjoon","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geralyn","family":"Annett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan A.","family":"Nolta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.addr.2010.09.013_bb0005","doi-asserted-by":"crossref","DOI":"10.2217\/rme.10.72","article-title":"Mesenchymal stem cells for the treatment of neurodegenerative disease","volume":"5","author":"Joyce","year":"2010","journal-title":"Regen. Med."},{"key":"10.1016\/j.addr.2010.09.013_bb0010","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/jcb.20886","article-title":"Mesenchymal stem cells as trophic mediators","volume":"98","author":"Caplan","year":"2006","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.addr.2010.09.013_bb0015","doi-asserted-by":"crossref","unstructured":"H.K. Salem, C. Thiemermann, Mesenchymal stromal cells: current understanding and clinical status. Stem Cells 28 (3) (2010) 585\u2013596.","DOI":"10.1002\/stem.269"},{"key":"10.1016\/j.addr.2010.09.013_bb0020","unstructured":"W.A. Noort, D. Feye, F. Van Den Akker, D. Stecher, S.A. Chamuleau, J.P. Sluijter, P.A. Doevendans, Mesenchymal stromal cells to treat cardiovascular disease: strategies to improve survival and therapeutic results. Panminerva Med. 52 (1) (2010) 27\u201340."},{"key":"10.1016\/j.addr.2010.09.013_bb0025","doi-asserted-by":"crossref","unstructured":"J. Tolar, K. Le Blanc, A. Keating, B.R. Blazar, Concise review: hitting the right spot with mesenchymal stromal cells. Stem Cells 28 (8) (2010) 1446\u20131455.","DOI":"10.1002\/stem.459"},{"key":"10.1016\/j.addr.2010.09.013_bb0030","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000071150","article-title":"Comparison of multi-lineage cells from human adipose tissue and bone marrow","volume":"174","author":"De Ugarte","year":"2003","journal-title":"Cells Tissues Organs"},{"key":"10.1016\/j.addr.2010.09.013_bb0035","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1089\/107632701300062859","article-title":"Multilineage cells from human adipose tissue: Implications for cell-based therapies","volume":"7","author":"Zuk","year":"2001","journal-title":"Tissue Eng."},{"key":"10.1016\/j.addr.2010.09.013_bb0040","series-title":"Establishment and transduction of primary human stromal\/mesenchymal stem cell monolayers","author":"Meyerrose","year":"2006"},{"key":"10.1016\/j.addr.2010.09.013_bb0045","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000047856","article-title":"The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion","volume":"169","author":"Gao","year":"2001","journal-title":"Cells Tissues Organs"},{"key":"10.1016\/j.addr.2010.09.013_bb0050","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.stem.2009.02.001","article-title":"Mesenchymal stem cell homing: The devil is in the details","volume":"4","author":"Karp","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.addr.2010.09.013_bb0055","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1097\/TP.0b013e3181a28533","article-title":"Mesenchymal stem cell homing capacity","volume":"87","author":"Sordi","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.addr.2010.09.013_bb0060","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1634\/stemcells.2006-0243","article-title":"In vivo distribution of human adipose-derived mesenchymal stem cells in novel xenotransplantation models","volume":"25","author":"Meyerrose","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.addr.2010.09.013_bb0065","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1634\/stemcells.2008-0008","article-title":"Lentiviral-transduced human mesenchymal stem cells persistently express therapeutic levels of enzyme in a xenotransplantation model of human disease","volume":"26","author":"Meyerrose","year":"2008","journal-title":"Stem Cells"},{"key":"10.1016\/j.addr.2010.09.013_bb0070","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/mt.2008.93","article-title":"In vivo biosafety model to assess the risk of adverse events from retroviral and lentiviral vectors","volume":"16","author":"Bauer","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2010.09.013_bb0075","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1080\/14653240601045399","article-title":"Mesenchymal stromal cells: Tissue repair and immune modulation","volume":"8","author":"Le Blanc","year":"2006","journal-title":"Cytotherapy"},{"key":"10.1016\/j.addr.2010.09.013_bb0080","first-page":"e37","article-title":"Adult bone marrow stem\/progenitor cells (MSCs) are preconditioned by microenvironmental \u201cniches\u201d in culture: A two-stage hypothesis for regulation of MSC fate","author":"Gregory","year":"2005","journal-title":"Sci. STKE"},{"key":"10.1016\/j.addr.2010.09.013_bb0085","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2217\/17460751.3.6.877","article-title":"Mesenchymal stem cells for vascular regeneration","volume":"3","author":"Huang","year":"2008","journal-title":"Regen. Med."},{"key":"10.1016\/j.addr.2010.09.013_bb0090","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/s12195-009-0090-6","article-title":"Proteomic profiling of mesenchymal stem cell responses to mechanical strain and TGF-beta1","volume":"2","author":"Kurpinski","year":"2009","journal-title":"Cell. Mol. Bioeng."},{"key":"10.1016\/j.addr.2010.09.013_bb0095","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/jcp.21592","article-title":"The therapeutic applications of multipotential mesenchymal\/stromal stem cells in skeletal tissue repair","volume":"218","author":"Arthur","year":"2009","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.addr.2010.09.013_bb0100","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/978-1-59745-060-7_18","article-title":"Bone-marrow-derived mesenchymal stem cells: Isolation, expansion, characterization, viral transduction, and production of conditioned medium","volume":"482","author":"Gnecchi","year":"2009","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.addr.2010.09.013_bb0105","series-title":"Genetic Engineering of Mesenchymal Stem Cells","author":"Nolta","year":"2006"},{"key":"10.1016\/j.addr.2010.09.013_bb0110","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1111\/j.1582-4934.2009.00857.x","article-title":"Mesenchymal stem cell-based therapy: A new paradigm in regenerative medicine","volume":"13","author":"Satija","year":"2009","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.addr.2010.09.013_bb0115","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/stem.150443","article-title":"Long-term cytokine production from engineered primary human stromal cells influences human hematopoiesis in an in vivo xenograft model","volume":"15","author":"Dao","year":"1997","journal-title":"Stem Cells"},{"key":"10.1016\/j.addr.2010.09.013_bb0120","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/00007890-197404000-00001","article-title":"Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues: Cloning in vitro and retransplantation in vivo","volume":"17","author":"Friedenstein","year":"1974","journal-title":"Transplantation"},{"key":"10.1016\/j.addr.2010.09.013_bb0125","first-page":"381","article-title":"Osteogenesis in transplants of bone marrow cells","volume":"16","author":"Friedenstein","year":"1966","journal-title":"J. Embryol. Exp. Morphol."},{"key":"10.1016\/j.addr.2010.09.013_bb0130","first-page":"393","article-title":"The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells","volume":"3","author":"Friedenstein","year":"1970","journal-title":"Cell Tissue Kinet."},{"key":"10.1016\/j.addr.2010.09.013_bb0135","first-page":"217","article-title":"Marrow microenvironment transfer by heterotopic transplantation of freshly isolated and cultured cells in porous sponges","volume":"10","author":"Friedenstein","year":"1982","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.addr.2010.09.013_bb0140","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1073\/pnas.92.11.4857","article-title":"Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice","volume":"92","author":"Pereira","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2010.09.013_bb0145","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1126\/science.276.5309.71","article-title":"Marrow stromal cells as stem cells for nonhematopoietic tissues","volume":"276","author":"Prockop","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.addr.2010.09.013_bb0150","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.addr.2010.09.013_bb0155","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/14653240500319234","article-title":"Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement","volume":"7","author":"Horwitz","year":"2005","journal-title":"Cytotherapy"},{"key":"10.1016\/j.addr.2010.09.013_bb0160","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1359\/jbmr.1997.12.9.1335","article-title":"Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo","volume":"12","author":"Kuznetsov","year":"1997","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.addr.2010.09.013_bb0165","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1172\/JCI10413","article-title":"Marrow stromal stem cells","volume":"105","author":"Bianco","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2010.09.013_bb0170","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1242\/jcs.1988.Supplement_10.5","article-title":"Marrow stromal stem cells","volume":"10","author":"Owen","year":"1988","journal-title":"J. Cell Sci. Suppl."},{"key":"10.1016\/j.addr.2010.09.013_bb0175","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/jcp.1041130414","article-title":"Stromal cell associated haemopoiesis","volume":"1","author":"Dexter","year":"1982","journal-title":"J. Cell. Physiol. Suppl."},{"key":"10.1016\/j.addr.2010.09.013_bb0180","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1182\/blood.V79.6.1393.1393","article-title":"Stromal support enhances cell-free retroviral vector transduction of human bone marrow long-term culture-initiating cells","volume":"79","author":"Moore","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.addr.2010.09.013_bb0185","first-page":"257","article-title":"Use of the bnx\/hu xenograft model of human hematopoiesis to optimize methods for retroviral-mediated stem cell transduction (Review)","volume":"1","author":"Dao","year":"1998","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.addr.2010.09.013_bb0190","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1182\/blood.V87.10.4082.bloodjournal87104082","article-title":"Functional heterogeneity of the hematopoietic microenvironment: Rare stromal elements maintain long-term repopulating stem cells","volume":"87","author":"Wineman","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.addr.2010.09.013_bb0195","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1089\/152581600319388","article-title":"Transplantation of gene-modified human bone marrow stromal cells into mouse\u2013human bone chimeras","volume":"9","author":"Brouard","year":"2000","journal-title":"J. Hematother. Stem Cell Res."},{"key":"10.1016\/j.addr.2010.09.013_bb0200","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1038\/sj.gt.3300973","article-title":"Bone marrow stromal cells as a vehicle for gene transfer","volume":"6","author":"Ding","year":"1999","journal-title":"Gene Ther."},{"key":"10.1016\/j.addr.2010.09.013_bb0205","article-title":"In vivo distribution of human adipose-derived MSC","author":"Meyerrose","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.addr.2010.09.013_bb0210","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1006\/mthe.2000.0094","article-title":"Critical factors influencing stable transduction of human CD34(+) cells with HIV-1-derived lentiviral vectors","volume":"2","author":"Haas","year":"2000","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2010.09.013_bb0215","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1073\/pnas.96.6.2988","article-title":"Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors","volume":"96","author":"Case","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.addr.2010.09.013_bb0220","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1182\/blood-2006-05-026039","article-title":"Cytokine and integrin stimulation synergize to promote higher levels of GATA-2, c-myb, and CD34 protein in primary human hematopoietic progenitors from bone marrow","volume":"109","author":"Dao","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.addr.2010.09.013_bb0225","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nm844","article-title":"Clonality analysis after retroviral-mediated gene transfer to CD34+ cells from the cord blood of ADA-deficient SCID neonates","volume":"9","author":"Schmidt","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2010.09.013_bb0230","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1182\/blood-2002-01-0025","article-title":"Reversibility of CD34 expression on human hematopoietic stem cells that retain the capacity for secondary reconstitution","volume":"101","author":"Dao","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.addr.2010.09.013_bb0235","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/sj.leu.2401781","article-title":"CD34: To select or not to select? That is the question","volume":"14","author":"Dao","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.addr.2010.09.013_bb0240","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1600-0609.1995.tb00701.x","article-title":"Retroviral-mediated gene transfer into human bone marrow stromal cells: Studies of efficiency and in vivo survival in SCID mice","volume":"55","author":"Li","year":"1995","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.addr.2010.09.013_bb0245","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1182\/blood.V83.10.3041.3041","article-title":"Sustained human hematopoiesis in immunodeficient mice by co-transplantation of marrow stroma expressing human interleukin-3: Analysis of gene transduction of long-lived progenitors","volume":"83","author":"Nolta","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.addr.2010.09.013_bb0250","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1097\/00003086-200010001-00011","article-title":"Mesenchymal stem cells as vehicles for gene delivery","author":"Mosca","year":"2000","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.addr.2010.09.013_bb0255","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1089\/hum.1997.8.12-1417","article-title":"LacZ and interleukin-3 expression in vivo after retroviral transduction of marrow-derived human osteogenic mesenchymal progenitors","volume":"8","author":"Allay","year":"1997","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.addr.2010.09.013_bb0260","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/sj.bmt.1703761","article-title":"W\/Wv marrow stromal cells engraft and enhance early erythropoietic progenitors in unconditioned Sl\/Sld murine recipients","volume":"30","author":"Bubnic","year":"2002","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.addr.2010.09.013_bb0265","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0301-472X(02)00821-4","article-title":"Failure of adult marrow-derived stem cells to generate marrow stroma after successful hematopoietic stem cell transplantation","volume":"30","author":"Awaya","year":"2002","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.addr.2010.09.013_bb0270","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/328429a0","article-title":"Host origin of marrow stromal cells following allogeneic bone marrow transplantation","volume":"328","author":"Simmons","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.addr.2010.09.013_bb0275","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0301-472X(99)00090-9","article-title":"Co-transplantation of stroma results in enhancement of engraftment and early expression of donor hematopoietic stem cells in utero","volume":"27","author":"Almeida-Porada","year":"1999","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.addr.2010.09.013_bb0280","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1182\/blood.V95.11.3620","article-title":"Co-transplantation of human stromal cell progenitors into preimmune fetal sheep results in early appearance of human donor cells in circulation and boosts cell levels in bone marrow at later time points after transplantation","volume":"95","author":"Almeida-Porada","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.addr.2010.09.013_bb0285","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0301-472X(02)00820-2","article-title":"Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD\/SCID mice","volume":"30","author":"Noort","year":"2002","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.addr.2010.09.013_bb0290","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0301-472X(03)00042-0","article-title":"Co-transplantation of human mesenchymal stem cells enhances human myelopoiesis and megakaryocytopoiesis in NOD\/SCID mice","volume":"31","author":"Angelopoulou","year":"2003","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.addr.2010.09.013_bb0295","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1126\/science.2904703","article-title":"Engraftment of immune-deficient mice with human hematopoietic stem cells","volume":"242","author":"Kamel-Reid","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.addr.2010.09.013_bb0300","first-page":"407","article-title":"Promotion of post BMT hematopoiesis reconstitution by co-transplantation of IL-3 transfected marrow stromal cells in mice","volume":"23","author":"Jiang","year":"2002","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.addr.2010.09.013_bb0305","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1038\/sj.leu.2402967","article-title":"Stage-specific alterations in serum levels of G-CSF in chronic myeloid leukaemia","volume":"17","author":"Jorgensen","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.addr.2010.09.013_bb0310","doi-asserted-by":"crossref","first-page":"170","DOI":"10.4049\/jimmunol.166.1.170","article-title":"IL-7 enhances the responsiveness of human T cells that develop in the bone marrow of athymic mice","volume":"166","author":"Tsark","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2010.09.013_bb0315","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.imlet.2004.11.018","article-title":"Cytokines transduced bone marrow stromal cell lines promote immunohematopoietic reconstitution in mice after allogeneic bone marrow transplantation","volume":"98","author":"Li","year":"2005","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.addr.2010.09.013_bb0320","first-page":"718a","article-title":"Primary human stromal cells engineered to secrete human erythropoietin (hEpo) promote terminal human red blood cell maturation in bnx\/hu mice","volume":"92","author":"Ertl","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.addr.2010.09.013_bb0325","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/sj.gt.3301919","article-title":"A neovascularized organoid derived from retrovirally engineered bone marrow stroma leads to prolonged in vivo systemic delivery of erythropoietin in nonmyeloablated, immunocompetent mice","volume":"10","author":"Eliopoulos","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.addr.2010.09.013_bb0330","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1681\/ASN.2005101035","article-title":"Erythropoietin delivery by genetically engineered bone marrow stromal cells for correction of anemia in mice with chronic renal failure","volume":"17","author":"Eliopoulos","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.addr.2010.09.013_bb0335","doi-asserted-by":"crossref","first-page":"F488","DOI":"10.1152\/ajprenal.00044.2008","article-title":"Mesenchymal stromal cells genetically engineered to overexpress IGF-I enhance cell-based gene therapy of renal failure-induced anemia","volume":"295","author":"Kucic","year":"2008","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.addr.2010.09.013_bb0340","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/path.2302","article-title":"Mesenchymal stem cell-based angiopoietin-1 gene therapy for acute lung injury induced by lipopolysaccharide in mice","volume":"214","author":"Xu","year":"2008","journal-title":"J. Pathol."},{"key":"10.1016\/j.addr.2010.09.013_bb0345","unstructured":"M. Griffin, U. Greiser, F. Barry, T. O'Brien, T. Ritter, Genetically modified mesenchymal stem cells and their clinical potential in acute cardiovascular disease, Discov. Med. 9 (46) (2010) 219\u2013223 (Review)."},{"key":"10.1016\/j.addr.2010.09.013_bb0350","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1111\/j.1582-4934.2008.00457.x","article-title":"Mesenchymal stem cells and cardiac repair","volume":"12","author":"Nesselmann","year":"2008","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.addr.2010.09.013_bb0355","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/039139880903200403","article-title":"Cell-based regeneration of intervertebral disc defects: Review and concepts","volume":"32","author":"Freimark","year":"2009","journal-title":"Int. J. Artif. Organs"},{"key":"10.1016\/j.addr.2010.09.013_bb0360","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2217\/17460751.4.1.99","article-title":"Genetically engineered mesenchymal stem cells: Applications in spine therapy","volume":"4","author":"Aslan","year":"2009","journal-title":"Regen. Med."},{"key":"10.1016\/j.addr.2010.09.013_bb0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainresrev.2009.03.003","article-title":"Regeneration of the ischemic brain by engineered stem cells: Fuelling endogenous repair processes","volume":"61","author":"van Velthoven","year":"2009","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.addr.2010.09.013_bb0370","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.nurt.2008.12.001","article-title":"Engineered adenosine-releasing cells for epilepsy therapy: Human mesenchymal stem cells and human embryonic stem cells","volume":"6","author":"Boison","year":"2009","journal-title":"Neurotherapeutics"},{"issue":"Suppl 1","key":"10.1016\/j.addr.2010.09.013_bb0375","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1016\/j.injury.2008.01.034","article-title":"Concepts in gene therapy for cartilage repair","volume":"39","author":"Steinert","year":"2008","journal-title":"Injury"},{"key":"10.1016\/j.addr.2010.09.013_bb0380","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1038\/mt.2008.197","article-title":"Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS","volume":"16","author":"Suzuki","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2010.09.013_bb0385","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10545-007-0483-4","article-title":"Clinical response to persistent, low-level beta-glucuronidase expression in the murine model of mucopolysaccharidosis type VII","volume":"30","author":"Donsante","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.addr.2010.09.013_bb0390","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1073\/pnas.87.10.3914","article-title":"Correction of murine mucopolysaccharidosis VII by a human beta-glucuronidase transgene","volume":"87","author":"Kyle","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2010.09.013_bb0395","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/sj.gt.3300797","article-title":"Autologous transplantation of retrovirally transduced bone marrow or neonatal blood cells into cats can lead to long-term engraftment in the absence of myeloablation","volume":"6","author":"Simonaro","year":"1999","journal-title":"Gene Ther."},{"key":"10.1016\/j.addr.2010.09.013_bb0400","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/360749a0","article-title":"Reversal of pathology in murine mucopolysaccharidosis type VII by somatic cell gene transfer","volume":"360","author":"Wolfe","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.addr.2010.09.013_bb0405","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1182\/blood.V82.4.1358.1358","article-title":"Disappearance of lysosomal storage in spleen and liver of mucopolysaccharidosis VII mice after transplantation of genetically modified bone marrow cells","volume":"82","author":"Marechal","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.addr.2010.09.013_bb0410","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/00007890-199308000-00034","article-title":"Continuous systemic secretion of a lysosomal enzyme by genetically modified mouse skin fibroblasts","volume":"56","author":"Moullier","year":"1993","journal-title":"Transplantation"},{"key":"10.1016\/j.addr.2010.09.013_bb0415","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nm0495-353","article-title":"Long-term delivery of a lysosomal enzyme by genetically modified fibroblasts in dogs","volume":"1","author":"Moullier","year":"1995","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2010.09.013_bb0420","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1182\/blood-2002-08-2597","article-title":"Engraftment of human CD34+ cells leads to widespread distribution of donor-derived cells and correction of tissue pathology in a novel murine xenotransplantation model of lysosomal storage disease","volume":"101","author":"Hofling","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.addr.2010.09.013_bb0425","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.ymthe.2004.03.013","article-title":"Human CD34+ hematopoietic progenitor cell-directed lentiviral-mediated gene therapy in a xenotransplantation model of lysosomal storage disease","volume":"9","author":"Hofling","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2010.09.013_bb0430","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1634\/stemcells.2007-0429","article-title":"Widespread nonhematopoietic tissue distribution by transplanted human progenitor cells with high aldehyde dehydrogenase activity","volume":"26","author":"Hess","year":"2008","journal-title":"Stem Cells"}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X10001912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X10001912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T04:33:39Z","timestamp":1759206819000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X10001912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":86,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0169409X10001912"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2010.09.013","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2010.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}